ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Hematology Oncology

Top Hematology Oncology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
H MATTHEWS MD

Hematology Oncology

851

$128K

103
87 are 65+

15%
patients receiving schedule two controlled substances

Avg: 13%

17%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$151
Average prescription price

Avg: $356

CHARLES TIBER MD

Hematology Oncology

825

$347K

117
93 are 65+

16%
patients receiving schedule two controlled substances

Avg: 13%

14%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 15%

$421
Average prescription price

Avg: $356

MATTHIAS WEISS MD

Hematology Oncology

822

$228K

100
85 are 65+

15%
patients receiving schedule two controlled substances

Avg: 13%

15%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 15%

$277
Average prescription price

Avg: $356

EDWARD PRENDERGAST MD

Hematology Oncology

819

$545K

138
111 are 65+

16%
patients receiving schedule two controlled substances

Avg: 13%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 15%

$666
Average prescription price

Avg: $356

HUSAM TARAWNEH M.D.

Hematology Oncology

818

$377K

115
75 are 65+

12%
patients receiving schedule two controlled substances

Avg: 13%

14%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 15%

$460
Average prescription price

Avg: $356

KEVIN MORTARA MD

Hematology Oncology

814

$442K

169
152 are 65+

12%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 15%

$543
Average prescription price

Avg: $356

TIMOTHY WASSENAAR MD

Hematology Oncology

812

$798K

81
70 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 15%

$983
Average prescription price

Avg: $356

WILLIAM CONKRIGHT MD

Hematology Oncology

811

$382K

182
143 are 65+

22%
patients receiving schedule two controlled substances

Avg: 13%

7%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 15%

$471
Average prescription price

Avg: $356

VARSHA SHAH M.D.

Hematology Oncology

810

$344K

117
90 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$425
Average prescription price

Avg: $356

ABHAY JELLA M.D.

Hematology Oncology

801

$323K

126
109 are 65+

13%
patients receiving schedule two controlled substances

Avg: 13%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$404
Average prescription price

Avg: $356

ALLAN TORKELSON M.D.

Hematology Oncology

796

$345K

103
90 are 65+

13%
patients receiving schedule two controlled substances

Avg: 13%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 15%

$434
Average prescription price

Avg: $356

MICHAEL HUSAK MD

Hematology Oncology

791

$398K

128
108 are 65+

9%
patients receiving schedule two controlled substances

Avg: 13%

12%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 15%

$504
Average prescription price

Avg: $356

KATHRYN BYLOW M.D.

Hematology Oncology

791

$576K

88
67 are 65+

18%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 15%

$728
Average prescription price

Avg: $356

MICHAEL THOMPSON MD, PHD

Hematology Oncology

787

$303K

89
76 are 65+

16%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$386
Average prescription price

Avg: $356

ROY KIM M.D.

Hematology Oncology

776

$715K

136
116 are 65+

10%
patients receiving schedule two controlled substances

Avg: 13%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 15%

$921
Average prescription price

Avg: $356

AMIT SANYAL MD

Hematology Oncology

774

$402K

134
125 are 65+

9%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 15%

$520
Average prescription price

Avg: $356

JOHN CHARLSON M.D.

Hematology Oncology

769

$119K

117
80 are 65+

17%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 15%

$155
Average prescription price

Avg: $356

PARAMESWARAN HARI MD

Hematology Oncology

756

$753K

110
68 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 15%

$996
Average prescription price

Avg: $356

PETER JOHNSON M.D.

Hematology Oncology

756

$257K

134
110 are 65+

11%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 15%

$340
Average prescription price

Avg: $356

JULES BLANK M.D.

Hematology Oncology

756

$352K

171
141 are 65+

9%
patients receiving schedule two controlled substances

Avg: 13%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$466
Average prescription price

Avg: $356

JOHN MAUL MD

Hematology Oncology

753

$346K

125
109 are 65+

17%
patients receiving schedule two controlled substances

Avg: 13%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 15%

$460
Average prescription price

Avg: $356

CHARLES BOMZER MD

Hematology Oncology

751

$381K

90
70 are 65+

21%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 15%

$507
Average prescription price

Avg: $356

KURT OESTERLING MD

Hematology Oncology

747

$577K

112
87 are 65+

16%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 15%

$773
Average prescription price

Avg: $356

SETH FAGBEMI MD

Hematology Oncology

743

$137K

118
100 are 65+

10%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 15%

$185
Average prescription price

Avg: $356

JEANNE PALMER M.D.

Hematology Oncology

735

$193K

52
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 15%

$263
Average prescription price

Avg: $356

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank